Clinical Trial Update: Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update investigates postoperative non-small cell lung cancer treated with an integrated medicine approach guided by circulating tumor c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: lihegen | Conditions: NSCLC | Phase 3 | Status: UNKNOWN